Tyler Jacks, MIT’s David H. Koch Professor of Biology and director of the Koch Institute for Integrative Cancer Research, will be appointed to the National Cancer Advisory Board (NCAB), the White House announced recently.
Jacks, who joined the MIT faculty in 1992 as part of the Department of Biology and former Center for Cancer Research, has pioneered the use of technology to study cancer-associated genes and to construct animal models of many human cancer types, including cancers of the lung, pancreas, brain and ovaries. He has served on the board of scientific advisors of the National Cancer Institute and the board of directors of the American Association of Cancer Research (AACR), and is also a past president of the AACR. He was elected to both the National Academy of Sciences and the Institute of Medicine of the National Academies in 2009.
The NCAB is an advisory committee of the National Cancer Institute. Its responsibilities include reviewing and recommending support grants and cooperative agreements. Each member’s term lasts six years.
In announcing Jacks’ appointment, along with several others, President Barack Obama said, “These fine public servants … bring a depth of experience and tremendous dedication to their new roles. Our nation will be well-served by these men and women, and I look forward to working with them in the months and years to come.”